ZyVersa Therapeutics Inc. (ZVSA)

ZyVersa Therapeutics Inc. (ZVSA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 21, 2026: market cap $647,673; returns 1 year -99.4%.

ZyVersa Therapeutics Inc. is a clinical-stage biopharmaceutical company that does not currently generate revenue. Its business model is centered on developing and commercializing a pipeline of first-in-class drug candidates based on two proprietary technology platforms.

Groups ZVSA belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Healthcare
• Monoclonal Antibodies
• Nephrology
• Metabolic Disorders
• Cardiovascular Therapies
• Drug Discovery

ZVSA financial model: income statement, cash flow and balance sheet